PacBio Unveils TRGT, A Tool For Characterizing Rare Disease

PacBio's TRGT can sequence broader sections of DNA, giving scientists and clinicians better odds of spotting repeated sections of DNA linked to disease.

sequencing graphic
• Source: Shutterstock

Pacific Biosciences (PacBio) recently revealed TRGT (pronounced “target”), a tool for identifying and quantifying tandem repeats in patients’ DNA profiles, which can then be correlated to disease. 

Tandem repeats are segments within DNA where nucleotides are repeated. 

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Diagnostics

More from Device Area